Adaptive Biotechnologies Corp (ADPT)

R&D Expenses

$19.15M

Quarterly · Period ending: · USD

ADPT logo

ADPT R&D Expenses

Latest reported$19.15M
ADPT Quarterly R&D Expenses ($8.86M → $19.15M)
High-resolution chart · PNG

ADPT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Adaptive Biotechnologies Corp R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
19,153,000
23,623,000
21,763,000
23,669,000
24,134,000
24,203,000
23,192,000
24,163,000
25,353,000
30,245,000
28,746,000
28,533,000
32,237,000
32,601,000
31,222,000
35,658,000
37,037,000
37,839,000
34,699,000
36,072,000
37,800,000
33,772,000
35,831,000
30,314,000
25,992,000
23,935,000
21,189,000
20,506,000
16,527,000
12,483,000
11,067,000
9,783,000
9,452,000
8,855,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.